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1. INTRODUCTION {#ijgo12468-sec-0008}
===============

The Global Burden of Disease (GBD) study group estimated that in 2013 alone, maternal conditions contributed to 18 027 800 disability‐adjusted life years, including morbidity from hemorrhage, infection, hypertension, abortion complications, obstructed labor, late and indirect maternal deaths, and those deaths aggravated by HIV.[1](#ijgo12468-bib-0001){ref-type="ref"} A recent publication suggested that the five main direct obstetric causes of morbidity resulted in 27 million morbid episodes in 2015.[2](#ijgo12468-bib-0002){ref-type="ref"} These sources, however, underestimate the true burden of disease attributable to pregnancy‐related conditions as they include only a few maternal conditions.[3](#ijgo12468-bib-0003){ref-type="ref"} They ignore common conditions, such as postpartum depression,[3](#ijgo12468-bib-0003){ref-type="ref"} and mild but prevalent conditions, such as urinary incontinence that affects over one‐third of the pregnant population in Europe alone.[4](#ijgo12468-bib-0004){ref-type="ref"}

The WHO recently published a comprehensive list of maternal morbidities, comprising 121 direct and indirect conditions.[5](#ijgo12468-bib-0005){ref-type="ref"} This list provides an important framework to understand what conditions constitute maternal morbidity, although the extent to which each of the listed morbidities contributes to the total burden remains unclear.[3](#ijgo12468-bib-0003){ref-type="ref"} Addressing this gap in our knowledge is necessary to better prioritize conditions for intervention. Furthermore, identifying the conditions that we know the least about is also important so they can be included in the future research agenda.[2](#ijgo12468-bib-0002){ref-type="ref"}

The aim of this systematic review is to identify existing systematic reviews quantifying the burden of each of the conditions identified in WHO\'s list of maternal morbidities. Compiling this information will enable us to: (1) make available the most up‐to‐date frequency (e.g. prevalence, incidence) estimates on each maternal condition; (2) identify which conditions lack reliable estimates; and (3) discuss the quality of the systematic reviews and the reliability of the available estimates.

2. MATERIALS AND METHODS {#ijgo12468-sec-0009}
========================

2.1. Search strategy {#ijgo12468-sec-0010}
--------------------

We conducted a systematic search in Embase, MEDLINE, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) using a combination of free text terms and Medical Subject Headings (MeSH terms). We combined terms for the following domains: pregnancy (e.g. maternal, antenatal), frequency of the disease (e.g. prevalence, incidence), publication type (e.g. systematic review, meta‐analysis), and specific terms for each of the 121 conditions described in the WHO maternal morbidity list by Chou et al.[5](#ijgo12468-bib-0005){ref-type="ref"} The search strategy was prepared by AL, CC, and GG, with input from VF, SW, and an experienced librarian. The complete strategy is provided in Appendix [S1](#ijgo12468-sup-0001){ref-type="supplementary-material"}. The search was restricted to humans and there were no language restrictions. The search was last run on July 23, 2016. In addition, we included further relevant systematic reviews known to the authors of this paper but not identified by the search, and we searched the reference lists of eligible studies. We used the MOOSE guidelines for conducting systematic reviews of observational studies to carry out and report on this review.[6](#ijgo12468-bib-0006){ref-type="ref"}

2.2. Inclusion and exclusion criteria for selection of systematic reviews {#ijgo12468-sec-0011}
-------------------------------------------------------------------------

We included peer‐reviewed systematic reviews that aimed to estimate the frequency of at least one of the maternal conditions listed in Chou et al.[5](#ijgo12468-bib-0005){ref-type="ref"} and which included estimates from at least two countries. The latter was a way to ensure we included estimates representing a region rather than a specific country. We included systematic reviews that included at least one paper published in or after 2006, as an attempt to provide recent estimates.

We excluded papers that: (1) did not mention frequency of the outcome among pregnant women in the abstract; (2) only reviewed studies for certain subgroups (e.g. rural women, or women with a specific health condition, women giving birth to twins, or women with a previous cesarean delivery); (3) focused only on risk factors or consequences of a certain maternal condition; (4) were not systematic reviews; (5) primarily included interventions for or investigated the effect of a single individual characteristic of the relevant maternal conditions; (6) were not possible to access in full; and (7) provided insufficient information on their inclusion and exclusion criteria in the text and the authors did not provide this information after we had attempted to contact them twice.

2.3. Data extraction {#ijgo12468-sec-0012}
--------------------

Data extraction from eligible reviews was carried out at two levels: (1) information on the overall paper; and (2) the specific frequency estimate. We did not extract information from the primary studies included in the eligible systematic reviews. For the study selection of the systematic reviews, one author (AL) screened titles and abstracts, and 10% of these were also screened by GG.

During the first level of data extraction, either AL, GG, or CC extracted data from eligible reviews such as the region reviewed, the databases searched, and the inclusion criteria applied for study selection. We also extracted detailed information on the quality of the systematic reviews. This was performed by AL with double extraction of 50% of the reviews (by GG). To assess the quality, we adapted the quality assessment tool for assessing systematic reviews proposed by Mann et al.,[7](#ijgo12468-bib-0007){ref-type="ref"} which is a modified version of the Overview Quality Assessment Questionnaire (OQAQ). Our adaptations included a question on whether authors clearly specified the source of the data---whether hospital, population, or unknown---and whether the search strategy was clearly laid out. The details on the modified OQAQ tool we used (which included 13 criteria) and the way we scored against it are available in Appendix [S2](#ijgo12468-sup-0002){ref-type="supplementary-material"}. We did not provide numerical summary quality scores for each eligible review because these could mask the relative importance of the different quality indicators. Instead, we used a traffic light system, and we calculated the overall proportion of articles scoring a specific color (e.g. green) for each question.

For the second level of data extraction, either GG or AL extracted the frequency estimates together with information on whether these were population‐ or facility‐based, the denominator for each, the countries they represented, the type of estimate (i.e. incidence or prevalence), and the diagnostic tools used for case ascertainment. Estimates were classified as population based if: (1) authors clearly said they were population based, or (2) the sample was recruited from facilities in countries where virtually all deliveries happen in facilities. For 50% of the papers included, we carried out double extraction of the frequency estimates and their details. Any discrepancies were resolved through discussion.

To select "the best" estimates to extract from systematic reviews where several frequency estimates were presented, we established the following rules that were applied in hierarchical order: Select population‐based estimates over (a) facility‐based estimates, or (b) estimates combining both facility‐ and population‐based estimates.When both pooled estimates (i.e. a weighted average) and the range of estimates from individual studies were provided, extract the pooled estimate.Select estimates covering the widest geographical area.Select the most recent estimates, in terms of data capture period.

For example, if a review reported a frequency estimate based on community‐based studies and a separate estimate for facility‐based studies, then we only extracted the estimate based on the community‐based studies. If a study reported weighted means based only on facility‐based studies separately for West Africa and for the whole of the African continent, then we selected only the estimate for Africa.

Estimates from systematic reviews where only a single study was identified are equivalent to reporting estimates from a single primary study; therefore, for the purposes of reporting estimates of maternal morbidity, we did not include estimates from such systematic reviews. For any reviews that were eligible based on our inclusion and exclusion criteria, but from which we could not extract a frequency estimate, we have included the paper in the main description but we do not report an estimate from it.

2.4. Analysis {#ijgo12468-sec-0013}
-------------

We transformed all estimates into percentages for presentation and comparison. For a particular review and each condition reported on, we present the frequency and the type of estimate (prevalence or incidence), the uncertainty range, region, pregnancy period, diagnostic tools, and data source (facility‐ vs population‐based). We report the region (or group of countries) for each estimate based on the countries covered by the primary studies included in the systematic review, which underpin each estimate. For those conditions reported by multiple eligible systematic reviews, we present estimates from each of those reviews. If those reviews reporting on the same condition included some of the same primary studies, we did not choose between the reviews because each review had distinct inclusion/exclusion criteria; for example, some reviews focused on certain countries or study designs. If a systematic review reported on multiple conditions of interest, we extracted estimates for each of these conditions.

3. RESULTS {#ijgo12468-sec-0014}
==========

We identified 11 930 results from searches across Embase, MEDLINE, and CINAHL, of which 3481 were duplicates and 8302 were unrelated to the topic of interest after screening the title and abstract (Fig. [1](#ijgo12468-fig-0001){ref-type="fig"}). A total of 150 papers were selected for full‐text review, of which three were added to the search results based on our previous knowledge. Full‐text review led to the exclusion of 102 papers for the reasons stated in Figure [1](#ijgo12468-fig-0001){ref-type="fig"}, including four articles that were excluded because they only reported composite outcomes, aggregating the frequency of multiple conditions in the WHO list.[8](#ijgo12468-bib-0008){ref-type="ref"}, [9](#ijgo12468-bib-0009){ref-type="ref"}, [10](#ijgo12468-bib-0010){ref-type="ref"}, [11](#ijgo12468-bib-0011){ref-type="ref"} We selected 48 eligible systematic reviews, and from searching their references we found one more. From these 49 eligible reviews, we extracted 34 direct and 60 indirect frequency estimates covering 35 conditions. The full list of included papers is provided in Appendix [S3](#ijgo12468-sup-0003){ref-type="supplementary-material"}.

![Study selection for inclusion in the systematic review.](IJGO-141-20-g001){#ijgo12468-fig-0001}

3.1. Availability of systematic reviews {#ijgo12468-sec-0015}
---------------------------------------

We found that for 71% of conditions in the WHO list by Chou et al.[5](#ijgo12468-bib-0005){ref-type="ref"} there was no systematic review available (Appendix [S3](#ijgo12468-sup-0003){ref-type="supplementary-material"}). The systematic reviews we found covered a substantial proportion (36%) of direct and coincidental maternal conditions, as well as several mental disorders (63%), and maternal infectious and parasitic diseases (46%). Under the direct morbidity umbrella, our search did not yield any systematic review for three categories: (1) pregnancy‐related infection, such as puerperal sepsis or mastitis; (2) cardiovascular obstetric complications such as peripartum cardiomyopathy; and (3) complications related to anesthesia.

In addition, we did not find any eligible systematic reviews for nine indirect morbidity categories listed by Chou et al.,[5](#ijgo12468-bib-0005){ref-type="ref"} as outlined in full in Appendix [S3](#ijgo12468-sup-0003){ref-type="supplementary-material"}. For example, none were found in the category called "Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium," which includes anemia, and we also found none under "Diseases of the musculoskeletal system and connective tissue," including back pain. A systematic review on anemia was not considered eligible because it aimed to review primary studies investigating the risk factors for anemia, therefore excluding studies that investigated the frequency of anemia but did not report on effect‐size estimates of risk factors.[12](#ijgo12468-bib-0012){ref-type="ref"}

Some conditions had multiple available systematic reviews. The highest number was identified for gestational diabetes (eight systematic reviews),[13](#ijgo12468-bib-0013){ref-type="ref"}, [14](#ijgo12468-bib-0014){ref-type="ref"}, [15](#ijgo12468-bib-0015){ref-type="ref"}, [16](#ijgo12468-bib-0016){ref-type="ref"}, [17](#ijgo12468-bib-0017){ref-type="ref"}, [18](#ijgo12468-bib-0018){ref-type="ref"}, [19](#ijgo12468-bib-0019){ref-type="ref"}, [20](#ijgo12468-bib-0020){ref-type="ref"} followed by infectious hepatitis, intimate partner violence, and postpartum depression, with four systematic reviews each. Although two systematic reviews were eligible and included, we have not reported frequency estimates for these because either the estimates were based on only one study per condition,[21](#ijgo12468-bib-0021){ref-type="ref"} or they reviewed a variety of conditions and denominators that were difficult to combine to present summary estimates here[22](#ijgo12468-bib-0022){ref-type="ref"}; details are provided in Appendix [S3](#ijgo12468-sup-0003){ref-type="supplementary-material"}.

3.2. Characteristics of available systematic reviews {#ijgo12468-sec-0016}
----------------------------------------------------

Details of the 94 frequency estimates extracted, including the denominator and the geographical area for each are presented by pregnancy period and by type of estimate in Table [1](#ijgo12468-tbl-0001){ref-type="table-wrap"} (direct maternal morbidities) and Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"} (indirect maternal morbidities). The systematic reviews used several types of prevalence (n=77) or incidence (n=17) estimates, including ranges, weighted means, crude means, and medians. The denominator varied according to the condition and the authors, and generally included births, pregnancies, deliveries, women of reproductive age (for fistula), and person‐years at risk (for HIV). Further details about the estimates are in Tables [1](#ijgo12468-tbl-0001){ref-type="table-wrap"} and [2](#ijgo12468-tbl-0002){ref-type="table-wrap"}, and additional details are provided in Appendix [S4](#ijgo12468-sup-0004){ref-type="supplementary-material"}.

###### 

Direct maternal morbidity estimates

  Condition                                          Author                                                         Group of countries or region   Type of estimate        Upper limit   Lower limit   Point estimate   No. of countries                            No. of studies or data sets[a](#ijgo12468-note-0003){ref-type="fn"}   Frequency type   Population source                                    Denominator                         Assessment/diagnostic method
  -------------------------------------------------- -------------------------------------------------------------- ------------------------------ ----------------------- ------------- ------------- ---------------- ------------------------------------------- --------------------------------------------------------------------- ---------------- ---------------------------------------------------- ----------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Unsafe severe abortion complications (ratio)       Adler, 2012[54](#ijgo12468-bib-0054){ref-type="ref"}           LMICs                          Median                  5.30%         0.435%        0.60%            8                                           9                                                                     Incidence        Population                                           Live births                         Clinical review
  Placenta previa                                    Cresswell, 2013[44](#ijgo12468-bib-0044){ref-type="ref"}       World                          Weighted mean           0.59%         0.45%         0.52%            25                                          41                                                                    Prevalence       Population[b](#ijgo12468-note-0004){ref-type="fn"}   Deliveries and live births          Clinical confirmation, not reported for 17/41 studies
  Nausea and vomiting                                Einarson, 2013[23](#ijgo12468-bib-0023){ref-type="ref"}        World                          Weighted average rate   72.30%        66.50%        69.40%           13                                          59                                                                    Prevalence       Not clear                                            Pregnancies                         Not clear
  Hyperemesis gravidarum                             Einarson, 2013[23](#ijgo12468-bib-0023){ref-type="ref"}        HICs                           Weighted average rate   3.60%         0.20%         1.20%            8                                           18                                                                    Prevalence       Not clear                                            Pregnancies                         Not clear
  Gestational diabetes                               Buckley, 2012[13](#ijgo12468-bib-0013){ref-type="ref"}         HICs                           Range                   22.30%        0.70%                          20                                          33                                                                    Prevalence       Population                                           Pregnancies, deliveries             Several diagnostic criteria, 1 study with unknown criteria
  Gestational diabetes                               Hirst, 2012[14](#ijgo12468-bib-0014){ref-type="ref"}           Asia                           Range                   17.70%        0.56%                          7                                           19                                                                    Prevalence       Population[b](#ijgo12468-note-0004){ref-type="fn"}   Pregnancies                         Diagnostic criteria included WHO, Japan Society of Obstetrics and Gynecology, NDDG, O\'Sullivan and Mahan,[71](#ijgo12468-bib-0071){ref-type="ref"} and Carpenter and Coustan[72](#ijgo12468-bib-0072){ref-type="ref"}
  Gestational diabetes                               Hunt, 2007[15](#ijgo12468-bib-0015){ref-type="ref"}            World                          Range                   22.30%        1.20%                          16                                          26                                                                    Prevalence       Population                                           Live births, pregnancies, unclear   Information missing for several studies. Included 1 study using self‐report
  Gestational diabetes                               Kanguru, 2014[19](#ijgo12468-bib-0019){ref-type="ref"}         LMICs                          Range                   17.25%        0.40%                          8                                           12                                                                    Prevalence       Population                                           Pregnancies                         Diagnostic criteria included WHO, ADA and IADSPSG
  Gestational diabetes                               Macaulay, 2014[16](#ijgo12468-bib-0016){ref-type="ref"}        Africa                         Range                   13.90%        0%                             6                                           14                                                                    Prevalence       Not clear                                            Not clear                           Several diagnostic criteria, including institutional protocols based on fast blood glucose
  Gestational diabetes                               Mwanri, 2015[17](#ijgo12468-bib-0017){ref-type="ref"}          Africa                         Weighted mean           10.01%        1.68%         5.06%            5[c](#ijgo12468-note-0005){ref-type="fn"}   13[c](#ijgo12468-note-0005){ref-type="fn"}                            Prevalence       Not clear                                            Not clear                           Not clear
  Gestational diabetes                               Schneider, 2012[18](#ijgo12468-bib-0018){ref-type="ref"}       HICs                           Range                   11.60%        1.70%                          10                                          27                                                                    Prevalence       Population                                           Pregnancies, births                 Self‐report/insulin test/glucose therapy/clinical diagnosis
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             Europe                         Median                  22.30%        1.80%         5.80%            12                                          Not clear                                                             Prevalence       Not clear                                            Not clear                           Several diagnostic criteria, some of which were not specified
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             North America and Caribbean    Median                  11.90%        6.50%         7.00%            4                                           Not clear                                                             Prevalence       Not clear                                            Not clear                           Several diagnostic criteria, some of which were not specified
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             South and Central America      Median                  16.60%        7.10%         11.20%           2                                           Not clear                                                             Prevalence       Not clear                                            Not clear                           Several diagnostic criteria, some of which were not specified
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             Middle East and North Africa   Median                  24.50%        8.40%         12.90%           5                                           Not clear                                                             Prevalence       Not clear                                            Not clear                           Diagnostic criteria included WHO, NDDG, IADSPG, Carpenter and Coustan[72](#ijgo12468-bib-0072){ref-type="ref"}
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             Africa                         Median                  9.50%         8.20%         8.90%            2                                           Not clear                                                             Prevalence       Not clear                                            Not clear                           Diagnostic criteria included WHO and IADPSG
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             South East Asia                Median                  18.30%        8.10%         11.70%           4                                           Not clear                                                             Prevalence       Not clear                                            Not clear                           Several diagnostic criteria, some of which were not specified
  Gestational diabetes                               Zhu, 2016[20](#ijgo12468-bib-0020){ref-type="ref"}             Western Pacific                Median                  25.10%        4.50%         11.70%           7                                           Not clear                                                             Prevalence       Not clear                                            Not clear                           Several diagnostic criteria, some of which were not specified
  Around delivery                                                                                                                                                                                                                                                                                                                                                                                                                                   
  Retained placenta (3rd stage of labor, \>30 min)   Cheung, 2011[55](#ijgo12468-bib-0055){ref-type="ref"}          HICs                           Median                  6.26%         2.00%         2.67%            4                                           6                                                                     Incidence        Not clear                                            Vaginal deliveries                  3rd stage labor at \>30 min, but not clear how recorded or by whom
  Retained placenta (3rd stage of labor, \>30 min)   Cheung, 2011[55](#ijgo12468-bib-0055){ref-type="ref"}          LMICs                          Median                  4.60%         1.05%         1.55%            3                                           3                                                                     Incidence        Not clear                                            Vaginal deliveries                  3rd stage labor at \>30 min, but not clear how recorded or by whom
  Retained placenta (MROP)                           Cheung, 2011[55](#ijgo12468-bib-0055){ref-type="ref"}          HICs                           Median                  5.42%         0.60%         2.40%            6                                           9                                                                     Incidence        Not clear                                            Vaginal deliveries                  MROP, but not clear how recorded or by whom
  Retained placenta (MROP)                           Cheung, 2011[55](#ijgo12468-bib-0055){ref-type="ref"}          LMICs                          Median                  0.57%         0.008%        0.43%            4                                           6                                                                     Incidence        Not clear                                            Vaginal deliveries                  MROP, but not clear how recorded or by whom.
  Pre‐eclampsia                                      Abalos, 2014[31](#ijgo12468-bib-0031){ref-type="ref"}          World                          Mean (range)            4.20%         1.20%         2.30%            31                                          52[a](#ijgo12468-note-0003){ref-type="fn"}                            Incidence        Both                                                 Deliveries                          Not clear: For 17% of pre‐eclampsia studies the outcome definition was not clear
  Eclampsia                                          Abalos, 2014[31](#ijgo12468-bib-0031){ref-type="ref"}          World                          Mean (range)            2.70%         0.10%         1.10%            28                                          42[a](#ijgo12468-note-0003){ref-type="fn"}                            Incidence        Both                                                 Deliveries                          Not clear: For 45% of eclampsia studies the outcome definition was not clear
  Postpartum hemorrhage (≥500 mL)                    Calvert, 2012[29](#ijgo12468-bib-0029){ref-type="ref"}         World                          Weighted mean           12.10%        9.60%         10.80%           29                                          63                                                                    Prevalence       Population[b](#ijgo12468-note-0004){ref-type="fn"}   Deliveries                          Objective, subjective, and unknown (21/104 data sets) methods of blood loss measurement were included
  Postpartum hemorrhage (≥500 mL)                    Carroli, 2008[30](#ijgo12468-bib-0030){ref-type="ref"}         World                          Weighted mean           6.05%         6%            6.02%            Not clear                                   14                                                                    Prevalence       Population                                           Deliveries                          Objective, subjective, and unspecified (14/55 studies) methods of blood loss measurement were included
  Severe postpartum hemorrhage (≥1000 mL)            Calvert, 2012[29](#ijgo12468-bib-0029){ref-type="ref"}         World                          Weighted mean           3.20%         2.40%         2.80%            27                                          37                                                                    Prevalence       Population[b](#ijgo12468-note-0004){ref-type="fn"}   Deliveries                          Objective, subjective, and unknown (6/69 data sets) methods of blood loss measurement were included
  Severe postpartum hemorrhage (≥1000 mL)            Carroli, 2008[30](#ijgo12468-bib-0030){ref-type="ref"}         World                          Weighted mean           1.71%         1.64%         1.67%            Not clear                                   4                                                                     Prevalence       Population                                           Deliveries                          Objective, subjective, and unspecified (2/25 studies) methods of blood loss measurement were included
  Amniotic fluid embolism                            Conde‐Agudelo, 2009[25](#ijgo12468-bib-0025){ref-type="ref"}   North America                  Weighted mean           0.0072%       0.0060%       0.0066%          2                                           3                                                                     Incidence        Population                                           Deliveries                          Not clear
  Amniotic fluid embolism                            Conde‐Agudelo, 2009[25](#ijgo12468-bib-0025){ref-type="ref"}   Europe                         Weighted mean           0.0021%       0.0017%       0.0019%          3                                           3                                                                     Incidence        Population                                           Deliveries                          Not clear
  Amniotic fluid embolism                            Frati, 2014[56](#ijgo12468-bib-0056){ref-type="ref"}           Not clear                      Mean (range)            0.02%         0.00%         0.01%            Not clear                                   8                                                                     Incidence        Not clear                                            Deliveries                          Clinical assessment
  3rd‐ and 4th‐degree perineal tear                  Villot, 2015[24](#ijgo12468-bib-0024){ref-type="ref"}          Not clear                      Range                   9.70%         2.95%         6.3250%          Not clear                                   3                                                                     Prevalence       Not clear                                            Not clear                           Not clear
  Pregnancy and postpartum                                                                                                                                                                                                                                                                                                                                                                                                                          
  Deep vein thrombosis                               Kourlaba, 2016[26](#ijgo12468-bib-0026){ref-type="ref"}        World                          Weighted mean           0.11%         0.10%         0.11%            7[c](#ijgo12468-note-0005){ref-type="fn"}   9[c](#ijgo12468-note-0005){ref-type="fn"}                             Incidence        Not clear                                            Pregnant and postpartum women       Not clear
  Deep vein thrombosis                               Meng, 2015[57](#ijgo12468-bib-0057){ref-type="ref"}            World                          Weighted mean           1.30%         1.00%         1.10%            10                                          18                                                                    Incidence        Not clear                                            Pregnant and postpartum women       Clinical review or tests (e.g. ultrasound).

Abbreviations: ADA, American Diabetes Association; EPDS, Edinburgh Postnatal Depression Scale; EASD, European Foundation for the Study of Diabetes; HICs, high‐income countries; IADSPSG, International Association of the Diabetes and Pregnancy Study Groups; LMICs, low‐ and middle‐income countries; NDDG, National Diabetes Data Group; MROP, manual removal of placenta.

Number of data sets.

Only included hospital‐based studies if the region in which the study was conducted had at least 95% of births attended by a skilled birth attendant. For Hirst et al.,[14](#ijgo12468-bib-0014){ref-type="ref"} this is because LMICs included have universal screening.

It was not clear whether the details for this matched the frequency estimate extracted.
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###### 

Indirect maternal morbidity estimates

  Condition                                        Author                                                        Group of countries            Type of estimate       Upper limit   Lower limit   Point estimate   No. of countries                             No. of studies or data sets[a](#ijgo12468-note-0007){ref-type="fn"}   Prevalence vs incidence   Population source                                    Denominator                                   Assessment method
  ------------------------------------------------ ------------------------------------------------------------- ----------------------------- ---------------------- ------------- ------------- ---------------- -------------------------------------------- --------------------------------------------------------------------- ------------------------- ---------------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------------------------------
  Pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Pre‐existing diabetes mellitus                   Kanguru, 2014[19](#ijgo12468-bib-0019){ref-type="ref"}        LMICs                         Range                  0.70%         0.00%                          6                                            7                                                                     Prevalence                Both                                                 Pregnancies                                   Diagnostic criteria included WHO, NDDG, EASD
  Malaria (peripheral parasitemia)                 Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          Eastern and Southern Africa   Weighted mean          36.50%        22.40%        29.50%           8                                            19                                                                    Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Malaria (peripheral parasitemia)                 Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          West and Central Africa       Weighted mean          41.90%        28.20%        35.10%           8                                            36                                                                    Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Malaria (placental parasitemia)                  Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          Eastern and Southern Africa   Weighted mean          36.40%        16.70%        26.50%           5                                            9                                                                     Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Malaria (placental parasitemia)                  Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          West and Central Africa       Weighted mean          47.60%        28.40%        38.00%           6                                            15                                                                    Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Hepatitis B (seroprevalence of HBsAg)            Merrill, 2011[58](#ijgo12468-bib-0058){ref-type="ref"}        World                         Median                                             4.30%            52[b](#ijgo12468-note-0008){ref-type="fn"}   98[b](#ijgo12468-note-0008){ref-type="fn"}                            Prevalence                Both                                                 Pregnancies                                   Laboratory
  HIV                                              Drake, 2014[36](#ijgo12468-bib-0036){ref-type="ref"}          Africa                        Weighted mean          6.10%         3.30%         4.70%            13                                           16                                                                    Incidence                 Not clear                                            Pregnancies (person years at risk)            Laboratory
  Hepatitis C                                      Mora, 2016[37](#ijgo12468-bib-0037){ref-type="ref"}           Sub‐Saharan Africa            Weighted mean          4.28%         1.46%         2.51%            Not clear                                    18                                                                    Prevalence                Not clear                                            Not clear                                     Laboratory
  Hepatitis C                                      Rao, 2015[38](#ijgo12468-bib-0038){ref-type="ref"}            Sub‐Saharan Africa            Random effects model   3.84%         2.23%         3.04%            10                                           21                                                                    Prevalence                Facility (ANC)                                       Pregnancies                                   Laboratory
  Hepatitis C                                      Riou, 2016[59](#ijgo12468-bib-0059){ref-type="ref"}           LMICs                         Range                  9.20%         0.20%                          15                                           28                                                                    Prevalence                Not clear                                            Pregnancies                                   Laboratory
  Chlamydia                                        Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          Eastern and Southern Africa   Weighted mean          7.10%         3.40%         5.20%            6                                            5                                                                     Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Chlamydia                                        Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          West and Central Africa       Weighted mean          3.50%         0.20%         1.90%            2                                            2                                                                     Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Chlamydia                                        Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Eastern Africa                Adjusted mean          5.60%         2.80%         4.20%            6[b](#ijgo12468-note-0008){ref-type="fn"}    3                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Chlamydia                                        Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Southern Africa               Adjusted mean          6.60%         2.30%         4.40%            6[b](#ijgo12468-note-0008){ref-type="fn"}    3                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Chlamydia                                        Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Latin America                 Adjusted mean          16.40%        6.00%         11.20%           5[b](#ijgo12468-note-0008){ref-type="fn"}    7                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Chlamydia                                        Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Asia                          Adjusted mean          1.10%         0.40%         0.80%            9[b](#ijgo12468-note-0008){ref-type="fn"}    6                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Syphilis                                         Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          Eastern and Southern Africa   Weighted mean          3.60%         2.10%         2.90%            8                                            17                                                                    Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Syphilis                                         Chico, 2012[27](#ijgo12468-bib-0027){ref-type="ref"}          West and Central Africa       Weighted mean          4.60%         0.40%         2.50%            4                                            5                                                                     Prevalence                Facility (ANC)                                       Women attending ANC                           Laboratory
  Syphilis                                         Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Eastern Africa                Adjusted mean          5.40%         3.70%         4.60%            6                                            8                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Syphilis                                         Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   West Africa                   Adjusted mean          6.30%         1.70%         4.00%            4[b](#ijgo12468-note-0008){ref-type="fn"}    4                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Syphilis                                         Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Southern Africa               Adjusted mean          8.30%         4.70%         6.50%            6[b](#ijgo12468-note-0008){ref-type="fn"}    8                                                                     Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Syphilis                                         Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Latin America                 Adjusted mean          3.30%         1.20%         2.20%            5[b](#ijgo12468-note-0008){ref-type="fn"}    15                                                                    Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Syphilis                                         Joseph Davey, 2016[60](#ijgo12468-bib-0060){ref-type="ref"}   Asia                          Adjusted mean          1.60%         0.50%         1.10%            9[b](#ijgo12468-note-0008){ref-type="fn"}    13                                                                    Prevalence                Both: estimates adjusted by setting                  Pregnancies                                   Laboratory
  Anogenital warts                                 Banura, 2013[61](#ijgo12468-bib-0061){ref-type="ref"}         Africa                        Range                  7.30%         0.20%                          5                                            11                                                                    Prevalence                Both                                                 Pregnancies                                   Clinical review
  Intimate partner violence                        Liepe, 2013[62](#ijgo12468-bib-0062){ref-type="ref"}          HICs                          Range                  31.70%        1.80%                          7                                            12                                                                    Prevalence                Not clear                                            Pregnancies                                   All validated questionnaires
  Intimate partner violence                        Puccia, 2012[63](#ijgo12468-bib-0063){ref-type="ref"}         World                         Range                  94%           3.40%                          9                                            16                                                                    Prevalence                Not clear                                            Pregnancies                                   5 studies not reported, 1 self‐reported, remaining used validated scales
  Intimate partner violence                        Shamu, 2011[64](#ijgo12468-bib-0064){ref-type="ref"}          Africa                        Weighted mean          16.08%        14.38%        15.23%           4                                            13                                                                    Prevalence                Both                                                 Pregnancies                                   Mixture of "own" tool with validated scales
  Depression                                       Sawyer, 2010[35](#ijgo12468-bib-0035){ref-type="ref"}         Africa                        Weighted mean          9.50%         13.10%        11.30%           3                                            5                                                                     Prevalence                Not clear                                            Pregnancies                                   20 studies conducted clinical interviews, 10 used self‐administered measures and 3 used both
  Depression (moderate to severe)                  Schmied, 2013[65](#ijgo12468-bib-0065){ref-type="ref"}        HICs                          Range                  20.50%        8.70%                          2                                            2                                                                     Prevalence                Not clear                                            Pregnancies                                   A variety of scales was used to assess depression; EPDS was the most often used
  Any anxiety disorder                             Goodman, 2014[28](#ijgo12468-bib-0028){ref-type="ref"}        World                         Range                  39.00%        4.40%                          8                                            10                                                                    Prevalence                Facility (ANC)                                       Pregnancies                                   Validated scale or clinical interview
  Anxiety                                          Sawyer, 2010[35](#ijgo12468-bib-0035){ref-type="ref"}         Africa                        Weighted mean          12.30%        17.40%        14.80%           1                                            2                                                                     Prevalence                Not clear                                            Pregnancies                                   Validated scale or clinical interview
  Bipolar disorder                                 Sharma, 2012[66](#ijgo12468-bib-0066){ref-type="ref"}         HICs                          Range                  1.40%         0%                             4                                            4                                                                     Prevalence                Population                                           Pregnancies                                   Interviews and self‐reported scales
  Generalized anxiety disorder                     Goodman, 2014[28](#ijgo12468-bib-0028){ref-type="ref"}        World                         Range                  10.50%        0.00%                          9                                            11                                                                    Prevalence                Facility (ANC)                                       Pregnancies                                   Validated scale or clinical interview
  Panic disorder                                   Goodman, 2014[28](#ijgo12468-bib-0028){ref-type="ref"}        World                         Range                  5.70%         0.20%                          9                                            12                                                                    Prevalence                Facility (ANC)                                       Pregnancies                                   Validated scale or clinical interview
  Post‐traumatic stress disorder                   Goodman, 2014[28](#ijgo12468-bib-0028){ref-type="ref"}        World                         Range                  7.90%         0.00%                          8                                            13                                                                    Prevalence                Facility (ANC)                                       Pregnancies                                   Validated scale or clinical interview
  Carpal tunnel syndrome                           Padua, 2010[67](#ijgo12468-bib-0067){ref-type="ref"}          Unclear region                Range                  43.00%        7%                             Not clear                                    5                                                                     Prevalence                Population                                           Pregnancies                                   Neurophysiologically confirmed
  Urinary incontinence                             Cerruto, 2013[4](#ijgo12468-bib-0004){ref-type="ref"}         HICs                          Range                  58.10%        6.70%                          Not clear                                    6                                                                     Prevalence                Population                                           Pregnancies                                   Questionnaires, some validated; 1 study no clear information
  Urinary incontinence                             Sangsawang, 2013[39](#ijgo12468-bib-0039){ref-type="ref"}     HICs                          Range                  75.00%        26%                            4                                            5                                                                     Prevalence                Population                                           Pregnancies                                   Not clear
  Postpartum                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  HIV                                              Drake, 2014[36](#ijgo12468-bib-0036){ref-type="ref"}          Africa                        Weighted mean          4.00%         1.80%         2.90%            3                                            7                                                                     Incidence                 Not clear                                            Postpartum women (person years at risk)       Laboratory
  Depression (minor and major)                     Norhayati, 2015[33](#ijgo12468-bib-0033){ref-type="ref"}      HICs                          Range                  62.00%        0.10%                          11                                           16                                                                    Prevalence                Not clear                                            Postpartum women                              Clinical interviews
  Depression (minor and major)                     Norhayati, 2015[33](#ijgo12468-bib-0033){ref-type="ref"}      LMICs                         Range                  26.30%        1%                             4                                            5                                                                     Prevalence                Not clear                                            Postpartum women                              Clinical interviews
  Major depressive disorders                       Norhayati, 2015[33](#ijgo12468-bib-0033){ref-type="ref"}      World                         Range                  62.00%        0.10%                          15                                           21                                                                    Prevalence                Not clear                                            Postpartum women                              Clinical interviews
  Depression                                       Parsons, 2012[34](#ijgo12468-bib-0034){ref-type="ref"}        LMICs                         Range                  50%           4.90%                          28                                           84                                                                    Prevalence                Not clear                                            Postpartum women                              Validated scales or clinical interviews
  Depression                                       Sawyer, 2010[35](#ijgo12468-bib-0035){ref-type="ref"}         Africa                        Weighted mean          19.10%        17.60%        18.30%           6                                            21                                                                    Prevalence                Not clear                                            Postpartum women                              Validated scales or clinical interviews
  Depression (moderate to severe)                  Schmied, 2013[65](#ijgo12468-bib-0065){ref-type="ref"}        HICs                          Range                  16.00%        9.00%                          2                                            Not clear                                                             Prevalence                Not clear                                            Postpartum women                              Validated scales or clinical interviews
  Post‐traumatic stress disorder                   Goodman, 2016[68](#ijgo12468-bib-0068){ref-type="ref"}        World                         Weighted mean          4.58%         0.66%         1.78%            4                                            6                                                                     Prevalence                Both                                                 Postpartum women                              Validated scales or clinical interviews
  Post‐traumatic stress disorder                   Grekin, 2014[69](#ijgo12468-bib-0069){ref-type="ref"}         World                         Weighted mean          3.90%         2.50%         3.10%            13                                           41                                                                    Prevalence                Population                                           Postpartum women                              Validated scales or clinical interviews
  Panic disorder                                   Goodman, 2016[68](#ijgo12468-bib-0068){ref-type="ref"}        World                         Weighted mean          2.76%         0.09%         1.66%            4                                            6                                                                     Prevalence                Both                                                 Postpartum women                              Validated scales or clinical interviews
  Anxiety disorder not otherwise specified (NOS)   Goodman, 2016[68](#ijgo12468-bib-0068){ref-type="ref"}        HICs                          Weighted mean          4.91%         0.01%         0.38%            2                                            2                                                                     Prevalence                Population                                           Postpartum women                              Clinical interviews
  Any anxiety disorder                             Goodman, 2016[68](#ijgo12468-bib-0068){ref-type="ref"}        World                         Weighted mean          13.83%        5.17%         8.56%            5                                            6                                                                     Prevalence                Population                                           Postpartum women                              Validated scales or clinical interviews
  Generalized anxiety disorder                     Goodman, 2016[68](#ijgo12468-bib-0068){ref-type="ref"}        World                         Weighted mean          6.66%         1.85%         3.59%            5                                            8                                                                     Prevalence                Both                                                 Postpartum women                              Validated scales or clinical interviews
  Anxiety                                          Sawyer, 2010[35](#ijgo12468-bib-0035){ref-type="ref"}         Africa                        Weighted mean          15.20%        12.90%        14.00%           2                                            2                                                                     Prevalence                Not clear                                            Postpartum women                              Validated scales or clinical interviews
  Urinary incontinence                             Cerruto, 2013[4](#ijgo12468-bib-0004){ref-type="ref"}         HICs                          Range                  31.00%        3.00%                          Not clear                                    6                                                                     Prevalence                Population                                           Postpartum women                              Questionnaires, some validated; 1 study no clear information
  Urinary incontinence                             Thom, 2010[42](#ijgo12468-bib-0042){ref-type="ref"}           HICs                          Mean                   36.00%        32.00%        33.00%           9                                            5                                                                     Prevalence                Population[c](#ijgo12468-note-0009){ref-type="fn"}   Postpartum women at 3 months                  Not clear
  Obstetric fistula                                Adler, 2013[32](#ijgo12468-bib-0032){ref-type="ref"}          LMICs                         Weighted mean          0.11%         0%            0.03%            9                                            10                                                                    Prevalence                Population                                           Women of reproductive age                     Physical exam
  Obstetric fistula                                Cowgill, 2015[40](#ijgo12468-bib-0040){ref-type="ref"}        LMICs                         Range                  0.41%         0.03%                          9                                            4                                                                     Prevalence                Population                                           Deliveries                                    Physical exam (not clear for modeled estimate from Nigeria)
  Obstetric fistula                                Zheng, 2009[41](#ijgo12468-bib-0041){ref-type="ref"}          LMICs                         Range                  1.56%         0.01%                          7                                            2                                                                     Incidence                 Population                                           Deliveries/live births                        Unvalidated questionnaires and physical exam
  Pregnancy and postpartum                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Malaria                                          Roberts, 2011[70](#ijgo12468-bib-0070){ref-type="ref"}        LMICs                         Range                  78.69%        0%                             13                                           43                                                                    Prevalence                Both                                                 Pregnant and postpartum women up to 42 days   Unclear, no information on 21% of the tests, remaining were laboratory‐based
  Pulmonary embolism                               Kourlaba, 2016[26](#ijgo12468-bib-0026){ref-type="ref"}       World                         Weighted mean          0.06%         0.02%         0.04%            7[b](#ijgo12468-note-0008){ref-type="fn"}    7[b](#ijgo12468-note-0008){ref-type="fn"}                             Incidence                 Not clear                                            Deliveries, pregnant and postpartum women     Not clear
  Pulmonary embolism                               Meng, 2015[57](#ijgo12468-bib-0057){ref-type="ref"}           World                         Weighted mean          0.04%         0.02%         0.03%            10                                           18                                                                    Incidence                 Not clear                                            Deliveries                                    Clinical review and diagnostic tests (e.g. ultrasound)

Abbreviations: ADA, American Diabetes Association; EPDS, Edinburgh Postnatal Depression Scale; EASD, European Foundation for the Study of Diabetes; HICs, high‐income countries; IADSPSG, International Association of the Diabetes and Pregnancy Study Groups; LMICs, low‐ and middle‐income countries; NDDG, National Diabetes Data Group; ANC, antenatal care.

Number of data sets.

It was not clear whether the details for this matched the frequency estimate extracted.

They define inclusion criteria for population as "studies on incontinence in population‐based sample defined as from one or more district hospitals or from multiple clinics covering a defined geographic area." However, two countries contributing to the estimates were Turkey and Iran, for which hospital recruitment might not always be entirely appropriate.

John Wiley & Sons, Ltd

The systematic reviews covered different geographical and economic areas, e.g. the world, high‐income countries (HICs), low‐ and middle‐income countries (LMICs), or specific regions (Africa, Asia, Europe, etc.). Of the estimates we extracted, 17 (18%) were based on only two countries or it was not clear from the paper how many countries were included. Among the frequency estimates that included worldwide studies, the median number of countries contributing data was 10 (interquartile range, 7.5--20.5). Sub‐Saharan Africa was the world region with the highest number of specifically dedicated systematic reviews (n=9).

Tables [1](#ijgo12468-tbl-0001){ref-type="table-wrap"} and [2](#ijgo12468-tbl-0002){ref-type="table-wrap"} describe the outcome assessment method behind each estimate. Information on assessment method at the estimate level was often scarce and poorly described. For direct morbidity estimates, the information on the assessment method underlying the estimates was unclear in five systematic reviews.[17](#ijgo12468-bib-0017){ref-type="ref"}, [23](#ijgo12468-bib-0023){ref-type="ref"}, [24](#ijgo12468-bib-0024){ref-type="ref"}, [25](#ijgo12468-bib-0025){ref-type="ref"}, [26](#ijgo12468-bib-0026){ref-type="ref"} In addition, some studies used assessment methods that are prone to bias. To take the example of gestational diabetes, Schneider et al.,[18](#ijgo12468-bib-0018){ref-type="ref"} and Hunt and Schuller [15](#ijgo12468-bib-0015){ref-type="ref"} included primary studies that used self‐report. Zhu and Zhang,[20](#ijgo12468-bib-0020){ref-type="ref"} on the other hand, reported clearly on diagnostic criteria at the estimate level.

3.3. Quality of systematic reviews {#ijgo12468-sec-0017}
----------------------------------

There was much variation in the quality of the 49 systematic reviews, including some examples of excellent methodology and reporting.[27](#ijgo12468-bib-0027){ref-type="ref"}, [28](#ijgo12468-bib-0028){ref-type="ref"}, [29](#ijgo12468-bib-0029){ref-type="ref"} Some aspects of quality were often found to be particularly poor, including insufficient reporting and methodological gaps (Fig. [2](#ijgo12468-fig-0002){ref-type="fig"}). For example, only 19 (39%) of the systematic reviews explicitly reported their language exclusions and the inclusion of grey literature, and only 21 (43%) provided a detailed description of the primary studies. Furthermore, for 16 (33%) of the reviews we did not have sufficient details on the data extraction process (e.g. use of independent extraction).

![Quality assessment.](IJGO-141-20-g002){#ijgo12468-fig-0002}

Information on data collection and sources was also lacking in many cases: for 19 (56%) of the direct morbidity estimates and 18 (30%) of the indirect estimates there was insufficient information to assess whether the data were from population‐ or facility‐based sources. Overall, 32 (34%) of the estimates extracted included data from facility‐based studies. Facility‐based studies vary in terms of their representativeness. For example, when reviewing studies of the prevalence of malaria, Chico et al.[27](#ijgo12468-bib-0027){ref-type="ref"} included women attending antenatal care clinics, a service that currently most African women attend at least once during pregnancy. Nevertheless, as the authors indicate, these estimates are only representative of those who attended antenatal care, and this paper includes studies from Africa going back at least two decades when antenatal care attendance was much lower.

One‐third (n=16; 32%) of the systematic reviews did not explicitly report whether they performed a quality assessment of their primary studies. Even when a quality assessment was conducted, most studies did not use a standardized tool or did not report which tool they used or the results. Publication bias was assessed by only 15% of the systematic reviews.

3.4. Frequency of maternal morbidity along the pregnancy--postpartum continuum {#ijgo12468-sec-0018}
------------------------------------------------------------------------------

As shown in Table [1](#ijgo12468-tbl-0001){ref-type="table-wrap"} and Figure [3](#ijgo12468-fig-0003){ref-type="fig"}, the toll of potentially life‐threatening direct maternal morbidities is high, with postpartum hemorrhage being the most common, estimated at 6.2% based on the review by Carroli et al.,[30](#ijgo12468-bib-0030){ref-type="ref"} and at 10.8% based on the more recent review with different population‐based criteria by Calvert et al.[29](#ijgo12468-bib-0029){ref-type="ref"} This is followed by pre‐eclampsia (2.3%),[31](#ijgo12468-bib-0031){ref-type="ref"} severe abortion complications (0.6%),[32](#ijgo12468-bib-0032){ref-type="ref"} and eclampsia (0.5%)[31](#ijgo12468-bib-0031){ref-type="ref"} (Table [1](#ijgo12468-tbl-0001){ref-type="table-wrap"}). Substantial direct maternal morbidity is also present throughout pregnancy with the prevalence of gestational diabetes mellitus estimated to be 5.1% in Africa[17](#ijgo12468-bib-0017){ref-type="ref"} and 25.1% in the Western Pacific Region (Table [1](#ijgo12468-tbl-0001){ref-type="table-wrap"}, Fig. [1](#ijgo12468-fig-0001){ref-type="fig"}).[20](#ijgo12468-bib-0020){ref-type="ref"}

![Population‐based estimates for direct maternal morbidities. Abbreviations: LMICs, low‐ and middle‐income coutries; HICs, high‐income countries. \[Colour figure can be viewed at <http://www.wileyonlinelibrary.com>\]](IJGO-141-20-g003){#ijgo12468-fig-0003}

The frequency of indirect maternal morbidity is also high (see Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"} and Fig. [4](#ijgo12468-fig-0004){ref-type="fig"}), particularly for mental health and infectious diseases. The prevalence of postpartum depression estimated for LMICs ranged from 1.0% to 26.3% according to Norhayati et al.[33](#ijgo12468-bib-0033){ref-type="ref"} and from 4.9% to 50% according to Parsons et al.[34](#ijgo12468-bib-0034){ref-type="ref"} In Africa, Sawyer et al.[35](#ijgo12468-bib-0035){ref-type="ref"} estimated the prevalence of pregnancy‐related depression at 18.3%. Anxiety is another common health problem, with prevalence worldwide ranging between 4.4% and 39.0%[28](#ijgo12468-bib-0028){ref-type="ref"} during pregnancy, and estimated to affect 8.5% of postpartum women on average.[28](#ijgo12468-bib-0028){ref-type="ref"} The average prevalence of anxiety during pregnancy and the postpartum period in Africa has been estimated at 14%[35](#ijgo12468-bib-0035){ref-type="ref"} (Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"}).

![Population‐based estimates for indirect maternal morbidities. Abbreviations: LMICs, low‐ and middle‐income countries; HICs, high‐income countries. \[Colour figure can be viewed at <http://www.wileyonlinelibrary.com>\]](IJGO-141-20-g004){#ijgo12468-fig-0004}

Regarding infectious diseases,[36](#ijgo12468-bib-0036){ref-type="ref"} the estimated pooled HIV incidence rate in Sub‐Saharan Africa is 4.7 per 100 person‐years during pregnancy and 2.9 per 100 person‐years during the postpartum period (Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"}). In Sub‐Saharan Africa, based on one systematic review,[27](#ijgo12468-bib-0027){ref-type="ref"} the reported prevalence of syphilis and chlamydia during pregnancy ranged between 2.5% and 2.9% and between 1.9% and 5.2%, respectively. Estimates of these conditions across LMICs, as reported in another systematic review, range between 0.5% and 8.3% for syphilis and between 0.4% and 16.4% for chlamydia (Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"}). Across Sub‐Saharan Africa, prevalence of malaria during pregnancy (peripheral parasitemia) ranges between 29.5% (in Eastern and Southern Africa) and 35.1% (in Western and Central Africa).[27](#ijgo12468-bib-0027){ref-type="ref"} Estimates for hepatitis are high, with a median of 4.3% of pregnancies diagnosed with seroprevalence of hepatitis B serum antigen (HBsAg), and between 2.5%[37](#ijgo12468-bib-0037){ref-type="ref"} and 3.0%[38](#ijgo12468-bib-0038){ref-type="ref"} of pregnant women in Africa infected with hepatitis C (Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"}).

Many pregnancies are affected by non‐life‐threatening conditions. Based on evidence predominately from HICs, nausea and vomiting have been reported to affect 69.4% of pregnant women[23](#ijgo12468-bib-0023){ref-type="ref"} (Table [1](#ijgo12468-tbl-0001){ref-type="table-wrap"}). Similarly, based on data from HICs, urinary incontinence has been variously estimated to affect 6.7% to 58.1%[4](#ijgo12468-bib-0004){ref-type="ref"} or 26.0% to 75.0%[39](#ijgo12468-bib-0039){ref-type="ref"} of women during pregnancy (Table [2](#ijgo12468-tbl-0002){ref-type="table-wrap"}).

Obstetric fistula, experienced by under 1% of postpartum women in LMICs, is one of the more severe although less prevalent maternal morbidities.[32](#ijgo12468-bib-0032){ref-type="ref"}, [40](#ijgo12468-bib-0040){ref-type="ref"}, [41](#ijgo12468-bib-0041){ref-type="ref"} Unrepaired fistulae can impact a woman\'s health and well‐being severely for the rest of her lifetime. Similarly, postpartum urinary incontinence can persist for a lifetime, and currently affects, on average, 33.0% of women during the puerperium in HICs according to one review,[42](#ijgo12468-bib-0042){ref-type="ref"} or between 3.0% and 31.0% as estimated in another review.[4](#ijgo12468-bib-0004){ref-type="ref"}

For some conditions, such as mental health disorders and infections, the timing of diagnosis may influence the frequency of the condition and thus explain differences in estimates between studies; this detail was not always reported. In Appendix [S5](#ijgo12468-sup-0005){ref-type="supplementary-material"}, we summarize the case for postpartum depression, for which there are notable differences between the systematic reviews in how they summarized data from longitudinal studies reporting prevalence data for more than one time point.

4. DISCUSSION {#ijgo12468-sec-0019}
=============

We conducted a systematic review of systematic reviews assessing the frequency of the 121 WHO maternal morbidities.[5](#ijgo12468-bib-0005){ref-type="ref"} Women suffer substantial morbidity during pregnancy, at the time of birth, and in the postpartum period. This review also identified important knowledge gaps. Surprisingly, no systematic reviews were available for several maternal conditions known to be potentially life‐threatening and some that can lead to long‐term disabilities, such as puerperal infection and anemia. Another important finding is that the quality of many of the 49 included systematic reviews was poor. Key areas for improvement include the strict inclusion of population‐based (rather than facility‐based) studies and improvement in the reporting of methods in line with available guidelines.

The importance of the time around delivery was traditionally emphasized in maternal health research as most maternal deaths occur in this period. However, our results show that the burden of maternal morbidity is also high before and after the point of delivery. Gestational diabetes affects at least 5% of women in low‐resource settings. Poor mental health is also common during pregnancy and in the postpartum period, with depression and anxiety the most common conditions. Infectious diseases are also frequent, including HIV, malaria, and hepatitis. These data call into question the completeness of currently available estimates on the overall burden of maternal morbidity (such as the ones provided by the GBD study group), as they rely on a limited number of highly prevalent maternal conditions, excluding, for example, gestational diabetes and anxiety.

Nevertheless, we have limited ability to comment on the frequency of 71% of the conditions listed by Chou et al.[5](#ijgo12468-bib-0005){ref-type="ref"} owing to the lack of systematic reviews for them. Furthermore, systematic reviews aiming to provide global estimates for a condition included a median of only 10 countries, which also casts some doubt on the geographical representativeness of currently available estimates of the burden of disease. This state of affairs has a number of possible explanations: (1) that maternal morbidity is not a research priority; (2) that some conditions are challenging to define and measure; and (3) that others are very rare and hence unlikely to be covered in a systematic review. Information on a wider range of maternal conditions and geographical areas should be gathered to produce better estimates.

The differences in prevalence reported for the same conditions, such as gestational diabetes and depression, may reflect actual differences between the populations and the widening inequalities between and within regions,[2](#ijgo12468-bib-0002){ref-type="ref"} but they are also likely to be driven by methodological differences between the systematic reviews and the primary studies they included. Potential drivers include different assessment methods, varying definitions of the condition, and differences in the study populations and the timing of assessment. For example, the type of assessment method applied can double prevalence estimates for a condition such as gestational diabetes.[16](#ijgo12468-bib-0016){ref-type="ref"} Generally, however, estimates for the same condition were relatively consistent; for example, estimates for postpartum hemorrhage varied between 6% and 11%, and obstetric fistula between 0% and 1.6% in LMICs.

Our results also highlight the existing gaps in the quality of methods and reporting used in systematic reviews on maternal conditions. Crucially, for 56% of the direct and 30% of the indirect estimates, there was insufficient information to verify the population or data source. Overall, 34% of the estimates extracted included facility‐based studies. As discussed elsewhere, more reliable population‐based estimates are needed, since mothers who access facilities are likely to be different to the ones who do not.[43](#ijgo12468-bib-0043){ref-type="ref"} Lack of facility attendance by women during pregnancy, delivery, and the postpartum period could lead to underestimation of the frequency of some conditions (e.g. if women tend not to seek help for that condition) or overestimation (e.g. if women with serious morbidity are more likely to attend a facility). Few systematic reviews used a rigorous method to select available data from LMICs for inclusion, such as only including hospital‐based studies if the region in which the study was conducted had at least 95% of births attended by a skilled birth attendant.[29](#ijgo12468-bib-0029){ref-type="ref"}, [44](#ijgo12468-bib-0044){ref-type="ref"} Other important limitations among the included systematic reviews included the potential for study selection bias, the inadequate use of quality‐assessment tools, reporting insufficient detail on the data extraction process, a poor description of the primary studies included, and lack of clarity about the diagnostic tools used to generate the estimates provided. Our findings on the poor quality of systematic reviews resonates with those of Sheick et al.,[45](#ijgo12468-bib-0045){ref-type="ref"} who reviewed the quality of systematic reviews on maternal medicine in 2007. A decade on, there is still much room for improvement.

We propose key steps to improve the quality of systematic reviews in the context of maternal morbidity, including the quality of the methods used to conduct them and the quality of the reporting. Our recommendations are similar to those proposed for estimating newborn morbidity[46](#ijgo12468-bib-0046){ref-type="ref"} and health estimates more broadly.[47](#ijgo12468-bib-0047){ref-type="ref"} These recommendations are addressed to the authors of systematic reviews, primary studies, study reviewers, and journal editors. First and foremost, researchers should use and report on studies according to standard guidelines for the review of observational studies, such as the PRISMA and STROBE guidelines.[6](#ijgo12468-bib-0006){ref-type="ref"}, [48](#ijgo12468-bib-0048){ref-type="ref"}, [49](#ijgo12468-bib-0049){ref-type="ref"}, [50](#ijgo12468-bib-0050){ref-type="ref"} In particular, we encourage the reporting of details on the eligible primary studies, including data source, sample size, and country.

Other important recommendations include: Explicitly report the data sources (facility‐ and/or population‐based) used to generate frequency estimates and for each primary study included. The gold standard is to restrict inclusion to primary studies that are population‐based, or restrict to those studies from geographical areas where the majority of women attend facility‐based services if included studies use facility‐based recruitment. If this is not possible, pooled estimates should be reported separately for studies that used population‐based and facility‐based data collection.Specify what assessment methods were used for each overall estimate presented. It is also good to report different summary estimates by diagnostic criteria. Try and avoid studies that include self‐reported data except when this is an acceptable way of measuring the condition (e.g. nausea and vomiting). If self‐reporting is included, discuss the primary studies assessing the validity of the self‐report (sensitivity and specificity).State the denominator used. Preferably prioritize pregnancies and postpartum women with clear definitions of this period (e.g. length of time postpartum, etc.).Use appropriate and standardized regional classifications based on the final list of primary studies included in the summary estimates provided.Provide frequency estimates at different points of the pregnancy--postpartum continuum, if relevant to the condition of interest.

Whether conditions arising during pregnancy should be quantified as incidence or prevalence heavily depends on the condition of interest, and the design and aims of a study. Yet many researchers use these terms interchangeably in the context of maternal morbidity; this is an issue that is beyond the scope of this study. However, we found that reviews of certain conditions for which incidence is of interest, such as postpartum depression, reported solely on prevalence. In systematic reviews, where several primary studies with a variety of designs are included, it can be difficult to choose the type of frequency to report. We call for future systematic reviews to clearly distinguish between incidence and prevalence estimates, to disaggregate these data, and to provide more discussion on this issue.

Our systematic review of systematic reviews is limited by the lack of grading based on diagnostic criteria. We chose not to perform such assessment because the primary studies in the included systematic reviews spanned across several conditions and decades, during which time the appropriateness of diagnostic criteria for different conditions changed. A further limitation is that we did not extract information directly from the primary studies identified by the systematic reviews---some systematic reviews included the same primary studies, and we did not always limit the time period for the publication of these primary studies---hence our reported frequencies represent a wide timescale. Overall, our review is limited by the quality of both the included systematic reviews and the primary studies they covered.

Finally, we only searched for systematic reviews rather than primary studies to assess the frequency of these conditions. We are aware of large‐scale analyses of the frequency of important conditions such as anemia,[51](#ijgo12468-bib-0051){ref-type="ref"} pregnancy‐related infection,[52](#ijgo12468-bib-0052){ref-type="ref"} and fistula,[53](#ijgo12468-bib-0053){ref-type="ref"} which provide robust estimates for these conditions. We chose to focus, however, on systematic reviews that use standardized methods to aggregate existing data.

In conclusion, this review highlights both the existence of substantial maternal morbidity---spanning the time before and beyond childbirth---and major remaining gaps in the availability of systematic reviews for some maternal morbidities. Future systematic reviews should improve their quality standards, including the strict inclusion of population‐based studies, and improvement of their review methods and their reporting, following available guidelines. With the changing burden of poor maternal health across the globe related to the obstetric transition, there is a pressing need to strengthen the evidence base for prioritizing action and further research. A central repository where results from new systematic reviews, using standardized terminology and metrics, can be stored and readily shared would be invaluable in tracking this shifting burden and in informing interventions to reduce the impact of maternal morbidities on women\'s lives.
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